ECSP13013080A - Derivados de pirazol útiles como inhibidores de aldosterona sintasa - Google Patents

Derivados de pirazol útiles como inhibidores de aldosterona sintasa

Info

Publication number
ECSP13013080A
ECSP13013080A ECSP13013080A ECSP13013080A EC SP13013080 A ECSP13013080 A EC SP13013080A EC SP13013080 A ECSP13013080 A EC SP13013080A EC SP13013080 A ECSP13013080 A EC SP13013080A
Authority
EC
Ecuador
Prior art keywords
inhibitors
aldosterona
sintasa
useful
pirazol derivatives
Prior art date
Application number
Other languages
English (en)
Inventor
Ana Maria Escribano
Thomas Mabry
Quanrong Shen
Michael Gregory Bell
Paul J Hoogestraat
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP13013080(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP13013080A publication Critical patent/ECSP13013080A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Abstract

La presente invención se refiere a inhibidores de aldosterona sintasa de la fórmula: intermediarios, métodos para su preparación, preparaciones farmacéuticas, y métodos para su uso.
ECSP13013080 2011-06-14 2013-12-13 Derivados de pirazol útiles como inhibidores de aldosterona sintasa ECSP13013080A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11

Publications (1)

Publication Number Publication Date
ECSP13013080A true ECSP13013080A (es) 2014-01-31

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13013080 ECSP13013080A (es) 2011-06-14 2013-12-13 Derivados de pirazol útiles como inhibidores de aldosterona sintasa

Country Status (33)

Country Link
US (1) US8778984B2 (es)
EP (1) EP2721009B1 (es)
JP (1) JP5890012B2 (es)
KR (1) KR101555119B1 (es)
CN (1) CN103596930B (es)
AR (1) AR086665A1 (es)
AU (1) AU2012271023A1 (es)
BR (1) BR112013031873A2 (es)
CA (1) CA2836804C (es)
CL (1) CL2013003536A1 (es)
CO (1) CO6821955A2 (es)
CR (1) CR20130601A (es)
CY (1) CY1116687T1 (es)
DK (1) DK2721009T3 (es)
DO (1) DOP2013000284A (es)
EA (1) EA201391655A1 (es)
EC (1) ECSP13013080A (es)
ES (1) ES2548210T3 (es)
GT (1) GT201300307A (es)
HK (1) HK1193103A1 (es)
HR (1) HRP20150939T1 (es)
HU (1) HUE026461T2 (es)
IL (1) IL229485A0 (es)
ME (1) ME02223B (es)
MX (1) MX336042B (es)
PE (1) PE20140606A1 (es)
PL (1) PL2721009T3 (es)
PT (1) PT2721009E (es)
RS (1) RS54269B1 (es)
SG (1) SG194822A1 (es)
SI (1) SI2721009T1 (es)
TW (1) TWI518073B (es)
WO (1) WO2012173849A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016002918A1 (ja) * 2014-07-04 2016-01-07 日本たばこ産業株式会社 インドール化合物の製造方法
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
WO2007111175A1 (ja) 2006-03-17 2007-10-04 Ngk Insulators, Ltd. 目封止ハニカム構造体の製造方法
ES2472446T3 (es) 2009-11-30 2014-07-01 Novartis Ag Derivados de imidazol como inhibidores de aldosterona sintasa
CN105440038A (zh) 2010-01-14 2016-03-30 诺华股份有限公司 肾上腺激素调节剂的用途

Also Published As

Publication number Publication date
SI2721009T1 (sl) 2015-10-30
EP2721009B1 (en) 2015-08-12
DOP2013000284A (es) 2014-06-30
MX336042B (es) 2016-01-07
HUE026461T2 (en) 2016-05-30
KR20140009564A (ko) 2014-01-22
CR20130601A (es) 2014-05-02
NZ617642A (en) 2015-11-27
CA2836804A1 (en) 2012-12-20
CL2013003536A1 (es) 2014-07-11
TW201311647A (zh) 2013-03-16
WO2012173849A1 (en) 2012-12-20
AR086665A1 (es) 2014-01-15
PT2721009E (pt) 2015-10-23
CN103596930B (zh) 2015-05-13
RS54269B1 (en) 2016-02-29
MX2013014790A (es) 2014-01-24
CA2836804C (en) 2016-05-24
KR101555119B1 (ko) 2015-09-22
US8778984B2 (en) 2014-07-15
AU2012271023A1 (en) 2013-11-28
DK2721009T3 (en) 2015-10-26
HK1193103A1 (en) 2014-09-12
HRP20150939T1 (en) 2015-10-09
JP2014517034A (ja) 2014-07-17
BR112013031873A2 (pt) 2016-12-13
US20120322841A1 (en) 2012-12-20
IL229485A0 (en) 2014-01-30
ES2548210T3 (es) 2015-10-14
GT201300307A (es) 2014-11-24
JP5890012B2 (ja) 2016-03-22
CN103596930A (zh) 2014-02-19
EP2721009A1 (en) 2014-04-23
CY1116687T1 (el) 2017-03-15
EA201391655A1 (ru) 2014-07-30
CO6821955A2 (es) 2013-12-31
PE20140606A1 (es) 2014-05-17
PL2721009T3 (pl) 2016-01-29
ME02223B (me) 2016-02-20
SG194822A1 (en) 2013-12-30
TWI518073B (zh) 2016-01-21

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
ECSP12011581A (es) Inhibidores de bace
CR11776A (es) Inhibidores de bace
GT201500138A (es) Novedososo derivados de bencimidazol como antagonistas de ep4
DOP2014000203A (es) Compuestos de heterociclilo
BR112015002755A2 (pt) derivado de ácido hialurônico, método de preparação de derivado de ácido hialurônico, método de modificação de derivado de ácido hialurônico e uso de derivados
AU2012213775A8 (en) 7-azaindole derivatives
ECSP14013251A (es) Derivados de 5-flúor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2(1h)ona
CO7020907A2 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
CR20140435A (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
DOP2014000036A (es) Compuestos de piridazinona y su uso como inhibidores daao
BR112014006482A2 (pt) uso de derivados de isossorbida para produção de preparações cosméticas
GT201400017A (es) Derivados de piridin-2 (1h) -ona como inhibidores de jak
CO6950507A2 (es) Compuestos de 1,2,5-oxadiazoly su uso como herbicidas ii
CO6970609A2 (es) Composición farmacéutica y métodos de uso de derivados de 4-pregenen-11ß-17-21-triol-3,20-diona
BR112014004310A2 (pt) composto de pirimidina inibidor da enzima fosfodiesterase 10, composição farmacêutica, uso de um composto
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
UY33874A (es) Derivados de ácido 3-heteroaroilamino-propiónico sustituidos y su uso como sustancias farmacéuticas
CO6751286A2 (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
BR112014018738A8 (pt) Métodos e intermediários para preparo de agentes farmacêuticos
ECSP13013016A (es) Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, y su uso como inhibidores de la cinasa del receptor vegf
GT201200328A (es) Intermedios de agomelatina y método de preparación de éstos
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
ECSP13013080A (es) Derivados de pirazol útiles como inhibidores de aldosterona sintasa
CU20150015A7 (es) Tris-(hetero)aril-pirazoles y su uso